Advertisement

Topics

Mentor Capital Reports 3rd Quarter 2017 10-Q

11:01 EST 10 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Increased Cash, Investments and Revenue Reported by Marijuana and Cannabis Company Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its quarterly 10-Q filing for the third quarter ended September 30, 2017 ...

Other Sources for this Article

Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700

NEXT ARTICLE

More From BioPortfolio on "Mentor Capital Reports 3rd Quarter 2017 10-Q"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...